{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:30:30Z","timestamp":1768563030351,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10252-5","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T19:53:23Z","timestamp":1738007603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lysophosphatidylcholine induces ceramide synthase-2 expression in primary culture model of astrocytopathy: potential therapeutic target in multiple sclerosis"],"prefix":"10.1007","volume":"52","author":[{"given":"Abhipsa","family":"Mohapatra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Amarjeet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskaranand","family":"Pancholi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selamu Kebamo","family":"Abate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-3926","authenticated-orcid":false,"given":"Debapriya","family":"Garabadu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"issue":"1","key":"10252_CR1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-022-00538-8","volume":"17","author":"M Zirngibl","year":"2022","unstructured":"Zirngibl M et al (2022) Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination. Mol Neurodegener 17(1):34","journal-title":"Mol Neurodegener"},{"key":"10252_CR2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/B978-0-323-98817-9.00016-8","volume":"196","author":"DS Younger","year":"2023","unstructured":"Younger DS (2023) Multiple sclerosis: motor dysfunction. Handb Clin Neurol 196:119\u2013147","journal-title":"Handb Clin Neurol"},{"key":"10252_CR3","unstructured":"Tafti, D., M. Ehsan, and K.L. Xixis, Multiple Sclerosis, in StatPearls. 2024, StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC.: Treasure Island (FL) ineligible companies. Disclosure: Moavia Ehsan declares no relevant financial relationships with ineligible companies. Disclosure: Kathryn Xixis declares no relevant financial relationships with ineligible companies."},{"issue":"4","key":"10252_CR4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2014.37","volume":"10","author":"MA Friese","year":"2014","unstructured":"Friese MA, Schattling B, Fugger L (2014) Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 10(4):225\u2013238","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10252_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/08164622.2021.1947745","volume":"105","author":"R Dhanapalaratnam","year":"2022","unstructured":"Dhanapalaratnam R, Markoulli M, Krishnan AV (2022) Disorders of vision in multiple sclerosis. Clin Exp Optom 105(1):3\u201312","journal-title":"Clin Exp Optom"},{"key":"10252_CR6","doi-asserted-by":"crossref","unstructured":"Portaccio, E., et al., Multiple sclerosis: emerging epidemiological trends and redefining the clinical course. 2024. 44.","DOI":"10.1016\/j.lanepe.2024.100977"},{"key":"10252_CR7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fneur.2015.00180","volume":"6","author":"J Correale","year":"2015","unstructured":"Correale J, Farez MF (2015) The role of astrocytes in multiple sclerosis progression. Front Neurol 6:180","journal-title":"Front Neurol"},{"issue":"2","key":"10252_CR8","first-page":"37","volume":"8","author":"IP Barcelos","year":"2019","unstructured":"Barcelos IP, Troxell RM, Graves JS (2019) Mitochondrial dysfunction and multiple sclerosis. Biology (Basel) 8(2):37","journal-title":"Biology (Basel)"},{"issue":"1","key":"10252_CR9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1750-3639.2011.00501.x","volume":"22","author":"S Kim","year":"2012","unstructured":"Kim S et al (2012) Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury. Brain Pathol 22(1):41\u201357","journal-title":"Brain Pathol"},{"issue":"5","key":"10252_CR10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/iub.319","volume":"62","author":"M Levy","year":"2010","unstructured":"Levy M, Futerman AH (2010) Mammalian ceramide synthases. IUBMB Life 62(5):347\u2013356","journal-title":"IUBMB Life"},{"issue":"7","key":"10252_CR11","doi-asserted-by":"crossref","first-page":"111224","DOI":"10.1016\/j.celrep.2022.111224","volume":"40","author":"MA Nyonda","year":"2022","unstructured":"Nyonda MA et al (2022) Ceramide biosynthesis is critical for establishment of the intracellular niche of Toxoplasma gondii. Cell Rep 40(7):111224","journal-title":"Cell Rep"},{"issue":"20","key":"10252_CR12","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.3390\/ijms20205031","volume":"20","author":"S Dasgupta","year":"2019","unstructured":"Dasgupta S, Ray SK (2019) Ceramide and sphingosine regulation of myelinogenesis: targeting serine palmitoyltransferase using microrna in multiple sclerosis. Int J Mol Sci 20(20):5031","journal-title":"Int J Mol Sci"},{"key":"10252_CR13","doi-asserted-by":"crossref","unstructured":"Rappoport, A., A Ceramide Theory of Multiple Sclerosis. 2024.","DOI":"10.20944\/preprints202409.1854.v1"},{"issue":"6","key":"10252_CR14","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","volume":"20","author":"K Kitatani","year":"2008","unstructured":"Kitatani K, Idkowiak-Baldys J, Hannun YA (2008) The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 20(6):1010\u20131018","journal-title":"Cell Signal"},{"issue":"1","key":"10252_CR15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12974-019-1436-1","volume":"16","author":"NM de Wit","year":"2019","unstructured":"de Wit NM et al (2019) Astrocytic ceramide as possible indicator of neuroinflammation. J Neuroinflammation 16(1):48","journal-title":"J Neuroinflammation"},{"key":"10252_CR16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neulet.2014.01.014","volume":"565","author":"AM Colangelo","year":"2014","unstructured":"Colangelo AM, Alberghina L, Papa M (2014) Astrogliosis as a therapeutic target for neurodegenerative diseases. Neurosci Lett 565:59\u201364","journal-title":"Neurosci Lett"},{"issue":"6","key":"10252_CR17","doi-asserted-by":"crossref","first-page":"e0178622","DOI":"10.1371\/journal.pone.0178622","volume":"12","author":"M Chami","year":"2017","unstructured":"Chami M et al (2017) Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination. PLoS ONE 12(6):e0178622","journal-title":"PLoS ONE"},{"issue":"11","key":"10252_CR18","doi-asserted-by":"crossref","first-page":"20614","DOI":"10.3390\/molecules201119721","volume":"20","author":"\u0141 Wo\u017aniak","year":"2015","unstructured":"Wo\u017aniak \u0141, Sk\u0105pska S, Marsza\u0142ek K (2015) Ursolic acid\u2014a pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules 20(11):20614\u201320641","journal-title":"Molecules"},{"issue":"9","key":"10252_CR19","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.3390\/ijms22094599","volume":"22","author":"E Gudoityte","year":"2021","unstructured":"Gudoityte E et al (2021) Ursolic and oleanolic acids: plant metabolites with neuroprotective potential. Int J Mol Sci 22(9):4599","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10252_CR20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/WNF.0000000000000528","volume":"45","author":"C Jiang","year":"2022","unstructured":"Jiang C et al (2022) Protective effects of ursodeoxycholic acid against oxidative stress and neuroinflammation through mitogen-activated protein kinases pathway in MPTP-induced parkinson disease. Clin Neuropharmacol 45(6):168\u2013174","journal-title":"Clin Neuropharmacol"},{"key":"10252_CR21","doi-asserted-by":"crossref","first-page":"1058358","DOI":"10.3389\/fphar.2022.1058358","volume":"13","author":"FJ Mirza","year":"2022","unstructured":"Mirza FJ, Zahid S (2022) Ursolic acid and rosmarinic acid ameliorate alterations in hippocampal neurogenesis and social memory induced by amyloid beta in mouse model of Alzheimer\u2019s disease. Front Pharmacol 13:1058358","journal-title":"Front Pharmacol"},{"issue":"3","key":"10252_CR22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4196\/kjpp.2018.22.3.235","volume":"22","author":"DY Seo","year":"2018","unstructured":"Seo DY et al (2018) Ursolic acid in health and disease. Korean J Physiol Pharmacol 22(3):235\u2013248","journal-title":"Korean J Physiol Pharmacol"},{"issue":"5","key":"10252_CR23","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/brainsci13050784","volume":"13","author":"S Madireddy","year":"2023","unstructured":"Madireddy S, Madireddy S (2023) Therapeutic strategies to Ameliorate neuronal damage in epilepsy by regulating oxidative stress, mitochondrial dysfunction, and neuroinflammation. Brain Sci 13(5):784","journal-title":"Brain Sci"},{"issue":"16","key":"10252_CR24","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1073\/pnas.2000208117","volume":"117","author":"Y Zhang","year":"2020","unstructured":"Zhang Y et al (2020) A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination. Proc Natl Acad Sci 117(16):9082\u20139093","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"10252_CR25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/glia.23245","volume":"66","author":"JR Plemel","year":"2018","unstructured":"Plemel JR et al (2018) Mechanisms of lysophosphatidylcholine-induced demyelination: a primary lipid disrupting myelinopathy. Glia 66(2):327\u2013347","journal-title":"Glia"},{"key":"10252_CR26","unstructured":"National Research Council Committee for the Update of the Guide for the, C. and A. Use of Laboratory, The National Academies Collection: Reports funded by National Institutes of Health, in Guide for the Care and Use of Laboratory Animals. 2011, National Academies Press (US) Copyright \u00a9 2011, National Academy of Sciences.: Washington (DC)."},{"key":"10252_CR27","doi-asserted-by":"publisher","DOI":"10.3791\/50079","author":"S Schildge","year":"2013","unstructured":"Schildge S et al (2013) Isolation and culture of mouse cortical astrocytes. J Vis Exp. https:\/\/doi.org\/10.3791\/50079","journal-title":"J Vis Exp"},{"issue":"3","key":"10252_CR28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11626-022-00666-x","volume":"58","author":"SK Dutta","year":"2022","unstructured":"Dutta SK, Sengupta S, Tripathi A (2022) In silico and in vitro evaluation of silibinin: a promising anti-chikungunya agent. In Vitro Cell Dev Biol Anim 58(3):255\u2013267","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"1\u20132","key":"10252_CR29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1\u20132):55\u201363","journal-title":"J Immunol Methods"},{"issue":"3","key":"10252_CR30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-012-1014-4","volume":"124","author":"R van Doorn","year":"2012","unstructured":"van Doorn R et al (2012) Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes. Acta Neuropathol 124(3):397\u2013410","journal-title":"Acta Neuropathol"},{"key":"10252_CR31","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.21769\/BioProtoc.374","volume":"3","author":"I Lakshmanan","year":"2013","unstructured":"Lakshmanan I, Batra SK (2013) Protocol for apoptosis assay by flow cytometry using annexin V staining method. Bio Protoc 3:e374","journal-title":"Bio Protoc"},{"key":"10252_CR32","first-page":"e60682","volume":"160","author":"H Kim","year":"2020","unstructured":"Kim H, Xue X (2020) Detection of total reactive oxygen species in adherent cells by 2\u2019, 7\u2019-dichlorodihydrofluorescein diacetate staining. JoVE J Visual Exp 160:e60682","journal-title":"JoVE J Visual Exp"},{"issue":"2","key":"10252_CR33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-010-0704-z","volume":"120","author":"R Sharma","year":"2010","unstructured":"Sharma R et al (2010) Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination. Acta Neuropathol 120(2):223\u2013236","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10252_CR34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1191\/1352458503ms931oa","volume":"9","author":"Y Morcos","year":"2003","unstructured":"Morcos Y, Lee SM, Levin MC (2003) A role for hypertrophic astrocytes and astrocyte precursors in a case of rapidly progressive multiple sclerosis. Mult Scler 9(4):332\u2013341","journal-title":"Mult Scler"},{"key":"10252_CR35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jneuroim.2016.09.010","volume":"299","author":"R Waller","year":"2016","unstructured":"Waller R et al (2016) Gene expression profiling of the astrocyte transcriptome in multiple sclerosis normal appearing white matter reveals a neuroprotective role. J Neuroimmunol 299:139\u2013146","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10252_CR36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jphs.2020.08.002","volume":"144","author":"S Yamamoto","year":"2020","unstructured":"Yamamoto S et al (2020) Ursolic acid treatment suppresses cuprizone-induced demyelination and motor dysfunction via upregulation of IGF-1. J Pharmacol Sci 144(3):119\u2013122","journal-title":"J Pharmacol Sci"},{"issue":"16","key":"10252_CR37","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1073\/pnas.2000208117","volume":"117","author":"Y Zhang","year":"2020","unstructured":"Zhang Y et al (2020) A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination. Proc Natl Acad Sci U S A 117(16):9082\u20139093","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10252_CR38","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1007\/s12031-022-02059-x","volume":"72","author":"F Honarvar","year":"2022","unstructured":"Honarvar F et al (2022) Ursolic acid enhances myelin repair in adult mice brains and stimulates exhausted oligodendrocyte progenitors to remyelinate. J Mol Neurosci 72:2081","journal-title":"J Mol Neurosci"},{"issue":"4","key":"10252_CR39","first-page":"1978","volume":"18","author":"F Honarvar","year":"2019","unstructured":"Honarvar F et al (2019) Myelin protection by ursolic acid in cuprizone-induced demyelination in mice. Iran J Pharm Res 18(4):1978\u20131988","journal-title":"Iran J Pharm Res"},{"key":"10252_CR40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.brainres.2010.07.016","volume":"1353","author":"A Defaux","year":"2010","unstructured":"Defaux A et al (2010) Inflammatory responses in aggregating rat brain cell cultures subjected to different demyelinating conditions. Brain Res 1353:213\u2013224","journal-title":"Brain Res"},{"issue":"1","key":"10252_CR41","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1038\/s41467-023-39046-8","volume":"14","author":"I Molina-Gonzalez","year":"2023","unstructured":"Molina-Gonzalez I et al (2023) Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration. Nat Commun 14(1):3372","journal-title":"Nat Commun"},{"issue":"4","key":"10252_CR42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/09731296231171454","volume":"19","author":"X-H Li","year":"2023","unstructured":"Li X-H et al (2023) The protective effect of ginkgolide K on astrocytes exposed to myelin debris in vitro and demyelination in vivo. Pharmacogn Mag 19(4):811\u2013821","journal-title":"Pharmacogn Mag"},{"issue":"1","key":"10252_CR43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s40168-024-01819-8","volume":"12","author":"B Han","year":"2024","unstructured":"Han B et al (2024) Dietary ellagic acid therapy for CNS autoimmunity: targeting on alloprevotella rava and propionate metabolism. Microbiome 12(1):114","journal-title":"Microbiome"},{"issue":"1","key":"10252_CR44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12974-016-0690-8","volume":"13","author":"R Okazaki","year":"2016","unstructured":"Okazaki R et al (2016) The crucial role of Erk2 in demyelinating inflammation in the central nervous system. J Neuroinflammation 13(1):235","journal-title":"J Neuroinflammation"},{"key":"10252_CR45","doi-asserted-by":"crossref","first-page":"115041","DOI":"10.1016\/j.bbr.2024.115041","volume":"469","author":"S Ashrafpour","year":"2024","unstructured":"Ashrafpour S et al (2024) Arbutin intervention ameliorates memory impairment in a rat model of lysolecethin induced demyelination: Neuroprotective and anti-inflammatory effects. Behav Brain Res 469:115041","journal-title":"Behav Brain Res"},{"key":"10252_CR46","doi-asserted-by":"crossref","first-page":"120446","DOI":"10.1016\/j.lfs.2022.120446","volume":"296","author":"A Tanaka","year":"2022","unstructured":"Tanaka A et al (2022) Ceramide kinase knockout ameliorates multiple sclerosis-like behaviors and demyelination in cuprizone-treated mice. Life Sci 296:120446","journal-title":"Life Sci"},{"issue":"11","key":"10252_CR47","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00403-001-0272-0","volume":"293","author":"DM Both","year":"2002","unstructured":"Both DM et al (2002) Liposome-encapsulated ursolic acid increases ceramides and collagen in human skin cells. Arch Dermatol Res 293(11):569\u2013575","journal-title":"Arch Dermatol Res"},{"issue":"5\u20136","key":"10252_CR48","first-page":"318","volume":"54","author":"DB Yarosh","year":"2000","unstructured":"Yarosh DB, Both D, Brown D (2000) Liposomal ursolic acid (merotaine) increases ceramides and collagen in human skin. Horm Res 54(5\u20136):318\u2013321","journal-title":"Horm Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10252-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10252-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10252-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:37:31Z","timestamp":1766853451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10252-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10252"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10252-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures in this study are in accordance with the Guide for the Care and Use of Laboratory Animals of the National Research Council US Committee for the update of the guide for the care and use of laboratory animals, 2011 and were approved by the Institutional Animal Ethics Committee approval (CUPB\/IAEC\/2022\/54) of the Central University of Punjab.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The Author confirms that the work described has not been published before.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}],"article-number":"166"}}